Howard Horn
2020
In 2020, Howard Horn earned a total compensation of $1.6M as Chief Financial Officer at Vir Biotechnology, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $226,100 |
|---|---|
| Option Awards | $960,186 |
| Salary | $444,333 |
| Other | $11,400 |
| Total | $1,642,019 |
Horn received $960.2K in option awards, accounting for 58% of the total pay in 2020.
Horn also received $226.1K in non-equity incentive plan, $444.3K in salary and $11.4K in other compensation.
Rankings
In 2020, Howard Horn's compensation ranked 6,436th out of 13,090 executives tracked by ExecPay. In other words, Horn earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,436 out of 13,090 | 51st |
Division Manufacturing | 2,654 out of 5,621 | 53rd |
Major group Chemicals And Allied Products | 1,072 out of 2,254 | 52nd |
Industry group Drugs | 926 out of 1,954 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 221 out of 411 | 46th |
Source: SEC filing on April 6, 2021.
Horn's colleagues
We found four more compensation records of executives who worked with Howard Horn at Vir Biotechnology in 2020.